Insulin-like growth factors and skeletal growth: Possibilities for therapeutic interventions

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 12, 1999, Pages 4349-4354

  Van Wyk, Judson J ^a   Smith, Eric P ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

BONE GROWTH; CHONDRODYSPLASIA; GENE DELETION; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN SECRETION; SEQUENCE ANALYSIS;

EID: 0033305562     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.12.6201     Document Type: Note

References (59)

1. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin
2. Sequence analysis of somatomedin-C: Confirmation of identity with insulin-like growth factor I
3. On the nomenclature of the somatomedins and insulin-like growth factors
4. Explorations of the insulin-like and growth-promoting properties of somatomedin by membrane receptor assays
5. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay
6. Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors
7. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis
8. A novel role for somatomedin-C in the cytodifferentiation of the ovarian granulosa cell
9. Thyrotropin potentiation of insulin-like growth factor-I dependent deoxyribonucleic acid synthesis in FRTL-5 cells: Mediation by an autocrine amplification factor(s)
10. Structural similarities between human receptors for somatomedin-C and insulin; Analysis by affinity labeling
11. Cellular patterns of insulin-like growth factor system gene expression in routine chondrogenesis and osteogenesis
12. Testosterone stimulates insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the mandibular condyle - A model of endochondral ossification
13. Insulin-like growth factor binding proteins in bone cell regulation
14. Insulin-like growth factors, and their binding proteins: Biological actions
15. Autocrine regulators of MC3T3-E1 cell proliferation
16. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells
17. Interaction of proteoglycans with the insulin-like growth factors and their binding proteins
18. Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I
19. Superior potency of refused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection
20. The mechanisms by which growth hormone brings about growth. The relative contributions of growth hormone and insulin-like growth factors
21. Normal growth and development in the absence of hepatic insulin-like growth factor-I
22. A dual effector theory of growth hormone action
23. Effects of insulin-like growth factor I treatment on statural growth, body composition and phenotype of children with growth hormone insensitivity syndrome
24. Growth hormone and bone
25. Role of insulin-like growth factors in embryonic and postnatal growth
26. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (IGF1r)
27. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by gene targeting
28. Loss of the imprinted IGF2/cation-dependent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality
29. Rescue of the T-associated maternal effect in mice carrying null mutations in IGF-2 and IGF-2r, two reciprocally imprinted genes
30. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene
31. Decreased insulin-like growth factor I receptor expression and function in immortalized African pygmy cells
32. Insulin-like growth factor-I receptor: Its role in cell proliferation, apoptosis, and tumorigenicity
33. Primary structure of human skeletal growth factor: Homology with human insulin-like growth factor II
34. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones
35. Estrogen regulation of the insulin-like growth factor-I gene transcription involves an AP-1 enhancer
36. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element
37. Cross-talk between peptide growth factors, and estrogen receptor signalling pathways
38. Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone
39. Insulin-like growth factor-I mediates osteoclast-like cell formation stimulated by parathyroid hormone
40. The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation
41. Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia
42. Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia
43. Fibroblast growth factor receptor 3 and the human chondrodysplasias
44. Effects of fibroblast growth factor-2 on longitudinal bone growth
45. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia 2
46. Control of bone growth by fibroblast growth factors
47. The endocrinology of the pubertal growth spurt
48. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement
49. The localization of androgen receptors in human bone
50. Demonstration of estrogen receptor-beta immunoreactivity in human growth plate cartilage
51. A preliminary study of the effect of estrogen dose on growth in Turner's syndrome
52. Estrogen treatment of tall girls: Dose dependency of effects on subsequent growth and IGF-I levels in blood
53. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
54. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
55. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
56. The secretion of adrenal androgens and growth patterns of patients with hypogonadotropic hypogonadism and idiopathic delayed puberty
57. Relation between growth hormone and somatomedin
58. Overexpression of IGFBP-4 in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia
59. The effects of the estrogen receptor blocker, Faslodex (ICI 182,780), on estrogen-accelerated bone maturation in mice